Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 3
1953 9
1954 13
1955 10
1956 15
1957 10
1958 6
1959 14
1960 13
1961 12
1962 17
1963 29
1964 48
1965 31
1966 36
1967 50
1968 53
1969 43
1970 66
1971 61
1972 81
1973 86
1974 79
1975 86
1976 68
1977 70
1978 64
1979 82
1980 70
1981 71
1982 71
1983 75
1984 98
1985 115
1986 100
1987 83
1988 71
1989 98
1990 111
1991 98
1992 94
1993 131
1994 104
1995 97
1996 94
1997 104
1998 128
1999 102
2000 111
2001 93
2002 109
2003 122
2004 131
2005 90
2006 96
2007 78
2008 118
2009 102
2010 107
2011 109
2012 124
2013 132
2014 127
2015 120
2016 127
2017 107
2018 105
2019 107
2020 113
2021 105
2022 101
2023 95
2024 45

Search Results

5,450 results

Results by year

Filters applied: . Clear all
Page 1
Hemophilia B (Factor IX Deficiency).
Sidonio RF Jr, Malec L. Sidonio RF Jr, et al. Hematol Oncol Clin North Am. 2021 Dec;35(6):1143-1155. doi: 10.1016/j.hoc.2021.07.008. Epub 2021 Oct 1. Hematol Oncol Clin North Am. 2021. PMID: 34607716 Review.
Factor IX(a) inhibitors: an updated patent review (2003-present).
Afosah DK, Ofori E, Mottamal M, Al-Horani RA. Afosah DK, et al. Expert Opin Ther Pat. 2022 Apr;32(4):381-400. doi: 10.1080/13543776.2022.2026926. Epub 2022 Jan 17. Expert Opin Ther Pat. 2022. PMID: 34991418 Free PMC article. Review.
Crippling down factor IX for therapeutic gain.
Strijbis VJF, Vatandoost J, Bos MHA. Strijbis VJF, et al. J Thromb Haemost. 2023 Dec;21(12):3287-3291. doi: 10.1016/j.jtha.2023.08.030. Epub 2023 Sep 6. J Thromb Haemost. 2023. PMID: 37678545 Review. No abstract available.
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
Pipe SW, Leebeek FWG, Recht M, Key NS, Castaman G, Miesbach W, Lattimore S, Peerlinck K, Van der Valk P, Coppens M, Kampmann P, Meijer K, O'Connell N, Pasi KJ, Hart DP, Kazmi R, Astermark J, Hermans CRJR, Klamroth R, Lemons R, Visweshwar N, von Drygalski A, Young G, Crary SE, Escobar M, Gomez E, Kruse-Jarres R, Quon DV, Symington E, Wang M, Wheeler AP, Gut R, Liu YP, Dolmetsch RE, Cooper DL, Li Y, Goldstein B, Monahan PE. Pipe SW, et al. N Engl J Med. 2023 Feb 23;388(8):706-718. doi: 10.1056/NEJMoa2211644. N Engl J Med. 2023. PMID: 36812434 Clinical Trial.
Factor IX for treating factor XI deficiency?
Gailani D. Gailani D. Blood. 2019 Aug 8;134(6):501-502. doi: 10.1182/blood.2019001826. Blood. 2019. PMID: 31395584 Free article. No abstract available.
Gene therapy for hemophilia.
Nathwani AC. Nathwani AC. Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):569-578. doi: 10.1182/hematology.2022000388. Hematology Am Soc Hematol Educ Program. 2022. PMID: 36485127 Free PMC article. Review.
Adeno-Associated Virus Gene Therapy for Hemophilia.
Samelson-Jones BJ, George LA. Samelson-Jones BJ, et al. Annu Rev Med. 2023 Jan 27;74:231-247. doi: 10.1146/annurev-med-043021-033013. Epub 2022 Sep 14. Annu Rev Med. 2023. PMID: 36103998 Free PMC article. Review.
Factor XI promotes hemostasis in factor IX-deficient mice.
Mohammed BM, Cheng Q, Matafonov A, Monroe DM, Meijers JCM, Gailani D. Mohammed BM, et al. J Thromb Haemost. 2018 Oct;16(10):2044-2049. doi: 10.1111/jth.14243. Epub 2018 Aug 16. J Thromb Haemost. 2018. PMID: 30007049 Free PMC article.
5,450 results